Teriflunomide
18 NDCs across 9 manufacturers|18 Generic,0 Brand
Teriflunomide is used to treat relapsing-remitting multiple sclerosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 12, 2012, and the first generic was approved Jul 27, 2018. FDA's Orange Book lists 28 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $234 million on Teriflunomide across 72,000 claims for 10,000 beneficiaries.
Teriflunomide is available as 18 NDCs from 9 manufacturers (18 generic, 0 brand), with NADAC prices from $0.23 to $0.75 per EA — the most expensive product costs about 3.2× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
18
18G / 0B
Manufacturers
9
competing in market
Price Spread
$0.23 – $0.75
per EA
7d Activity
avg -1.7% WoW · of 18 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Accord Healthcare Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Pyrimidine Synthesis Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
9 manufacturers producing TERIFLUNOMIDE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TERIFLUNOMIDE 14 MG TABLET | $0.7487 per EA | — |
TERIFLUNOMIDE 7 MG TABLET | $0.6037 per EA | — |
TERIFLUNOMIDE 7 MG TABLET | $0.2919 per EA | +0.06% |
TERIFLUNOMIDE 7 MG TABLET | $0.2919 per EA | +0.06% |
TERIFLUNOMIDE 7 MG TABLET | $0.2919 per EA | +0.06% |
TERIFLUNOMIDE 7 MG TABLET | $0.2919 per EA | +0.06% |
TERIFLUNOMIDE 7 MG TABLET | $0.2919 per EA | +0.06% |
TERIFLUNOMIDE 7 MG TABLET | $0.2919 per EA | +0.06% |
TERIFLUNOMIDE 7 MG TABLET | $0.2919 per EA | +0.06% |
TERIFLUNOMIDE 7 MG TABLET | $0.2919 per EA | +0.06% |
TERIFLUNOMIDE 14 MG TABLET | $0.2334 per EA | -3.39% |
TERIFLUNOMIDE 14 MG TABLET | $0.2334 per EA | -3.39% |
TERIFLUNOMIDE 14 MG TABLET | $0.2334 per EA | -3.39% |
TERIFLUNOMIDE 14 MG TABLET | $0.2334 per EA | -3.39% |
TERIFLUNOMIDE 14 MG TABLET | $0.2334 per EA | -3.39% |
TERIFLUNOMIDE 14 MG TABLET | $0.2334 per EA | -3.39% |
TERIFLUNOMIDE 14 MG TABLET | $0.2334 per EA | -3.39% |
TERIFLUNOMIDE 14 MG TABLET | $0.2334 per EA | -3.39% |
Frequently Asked Questions
What is Teriflunomide used to treat?
Teriflunomide is used to treat relapsing-remitting multiple sclerosis, per the National Library of Medicine's MED-RT classification.
When did Teriflunomide become available as a generic?
FDA approved the first generic Teriflunomide (ANDA) on Jul 27, 2018. The Orange Book currently lists 28 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Teriflunomide?
In 2024, Medicare Part D spent $234 million on Teriflunomide across 72,000 claims for 10,000 beneficiaries.
How many Teriflunomide products are on the market?
The Teriflunomide drug market contains 18 NDCs from 9 manufacturers — 18 generic and 0 brand products.
What is the price range for Teriflunomide?
NADAC reference prices for Teriflunomide range from $0.2334 to $0.7487 per EA — the most expensive product costs about 3.2× the cheapest.
Which manufacturers make Teriflunomide?
9 manufacturers list Teriflunomide in NADAC. Ranked by number of NDCs, the largest are Accord Healthcare Inc. (2), SOLA Pharmaceuticals LLC (2), Alembic Pharmaceuticals Inc. (2), Zydus Pharmaceuticals (USA) Inc. (2), Teva Pharmaceuticals USA Inc. (2).
How has the price of Teriflunomide changed recently?
Over the past 7 days, 8 Teriflunomide NDCs rose and 8 fell, with a market-wide average change of -1.7%.